You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

Endometrial Cancer Molecular Testing Recommendations Report

Version: 1 nov 2024
Type of Content: Guidelines & Advice
Document Status: Current
Authors:
Endometrial Cancer Molecular Testing Working Group Members

Guideline Objective

The objectives of this guideline are:

  1. To ensure the approach to molecular testing for endometrial cancer is consistent across the province, and;
  2. Help physicians appropriately triage and facilitate the treatment of patients with endometrial cancer.

Intended Guideline Users

Hospital and community-based pathologists with a special interest in gynecologic cancers, gynecologists, gynecologic oncologists, and other healthcare professionals who care for patients with endometrial cancer, including radiation oncologists and medical oncologists.

pdf download Full Report (PDF) (2.23 Mo)